Cleared Traditional

K033106 - CAPTIA HSV 2 IGG TYPE SPECIFIC ELISA KIT

K033106 is an FDA 510(k) clearance for CAPTIA HSV 2 IGG TYPE SPECIFIC ELISA KIT, manufactured by Trinity Biotech USA. The device is a Class 2 Microbiology device with product code MYF cleared through the Traditional 510(k) pathway after a 287-day FDA review.

K033106 · Trinity Biotech USA · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2004
Decision
287d
Days
Class 2
Risk

K033106 is an FDA 510(k) clearance for the CAPTIA HSV 2 IGG TYPE SPECIFIC ELISA KIT. Classified as Enzyme Linked Immunosorbent Assay, Herpes Simplex Virus, Hsv-2 (product code MYF), Class II - Special Controls.

Submitted by Trinity Biotech USA (Jamestown, US). The FDA issued a Cleared decision on July 13, 2004 after a review of 287 days - an extended review cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3305 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Trinity Biotech USA devices

FDA 510(k) Submission Details - K033106

510(k) Number K033106 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 30, 2003
Decision Date July 13, 2004
Days to Decision 287 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
185d slower than avg
Panel avg: 102d · This submission: 287d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MYF Device Classification - Class 2, Special Controls

Product Code MYF Enzyme Linked Immunosorbent Assay, Herpes Simplex Virus, Hsv-2
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.3305
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - MYF Enzyme Linked Immunosorbent Assay, Herpes Simplex Virus, Hsv-2

All 8
Devices cleared under the same product code (MYF) and FDA review panel - the closest regulatory comparables to K033106.
SeraQuest HSV Type 2 Specific IgG
K152353 · Quest International, Inc. · May 2016
ZEUS ELISA HSV GG-2 IGG TEST SYSTEM
K103603 · Zeus Scientific, Inc. · May 2011
LIAISON HSV-2 TYPE SPECIFIC IGG ASSAY, CONTROL HSV-2 IGG
K081687 · DiaSorin, Inc. · Nov 2008
HSV-2 ELISA IGG, MODEL EL0920G
K993724 · Mrl Diagnostics · Feb 2000